Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal morphology of female internal genitalia (HP:0000008)help
Grandparent Node:
expand
Irregular menstruation (HP:0000858)help
Parent Node:
expand
Abnormal bleeding (HP:0001892)help
Parent Node:
expand
Abnormality of the menstrual cycle (HP:0000140)help
..Starting node
..expand
Menorrhagia (HP:0000132)help
Term ID: 132
Name: Menorrhagia
Synonym: Abnormally heavy bleeding during menstruation; Abnormally heavy periods; Hypermenorrhea
Definition: Prolonged and excessive menses at regular intervals in excess of 80 mL or lasting longer than 7 days.
Comments:
Reference: HP:0000132
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAmenorrhea (HP:0000141) help
..expandDelayed menarche (HP:0012569) help
..expandMenometrorrhagia (HP:0400008) help
..expandMetrorrhagia (HP:0100608) help
..expandOligomenorrhea (HP:0000876) help
..expandPolymenorrhea (HP:0400007) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000132HP:0000132Menorrhagia0BLOC1S3 CL E G H38855220914OMIM:614077Hermansky-Pudlak syndrome 8.42
HP:0000132HP:0000132Menorrhagia0BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0000132HP:0000132Menorrhagia0DIAPH1 CL E G H17292876OMIM:124900Deafness, autosomal dominant 1118
HP:0000132HP:0000132Menorrhagia0F10 CL E G H21593528ORPHA:328Congenital factor X deficiencyHP:0040283 - Occasional33
HP:0000132HP:0000132Menorrhagia0F10 CL E G H21593528OMIM:227600Factor X deficiency.33
HP:0000132HP:0000132Menorrhagia0F11 CL E G H21603529ORPHA:329Congenital factor XI deficiencyHP:0040282 - Frequent132
HP:0000132HP:0000132Menorrhagia0F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiencyHP:0040283 - Occasional60
HP:0000132HP:0000132Menorrhagia0F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiencyHP:0040283 - Occasional32
HP:0000132HP:0000132Menorrhagia0F2 CL E G H21473535ORPHA:325Congenital factor II deficiencyHP:0040283 - Occasional44
HP:0000132HP:0000132Menorrhagia0F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency.44
HP:0000132HP:0000132Menorrhagia0F5 CL E G H21533542ORPHA:326Congenital factor V deficiencyHP:0040283 - Occasional159
HP:0000132HP:0000132Menorrhagia0F5 CL E G H21533542OMIM:227400Factor V deficiency.159
HP:0000132HP:0000132Menorrhagia0F7 CL E G H21553544ORPHA:327Congenital factor VII deficiencyHP:0040282 - Frequent70
HP:0000132HP:0000132Menorrhagia0F7 CL E G H21553544OMIM:227500Factor VII deficiency.70
HP:0000132HP:0000132Menorrhagia0F8 CL E G H21573546ORPHA:177926Bleeding disorder in hemophilia A carriers without FVIII deficiencyHP:0040282 - Frequent303
HP:0000132HP:0000132Menorrhagia0F8 CL E G H21573546ORPHA:169802Severe hemophilia AHP:0040283 - Occasional303
HP:0000132HP:0000132Menorrhagia0FLI1 CL E G H23133749OMIM:617443Bleeding disorder, platelet-type, 21.8
HP:0000132HP:0000132Menorrhagia0GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent23
HP:0000132HP:0000132Menorrhagia0GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant.23
HP:0000132HP:0000132Menorrhagia0GP1BA CL E G H28114439OMIM:231200BERNARD-SOULIER SYNDROME; BSS23
HP:0000132HP:0000132Menorrhagia0GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent8
HP:0000132HP:0000132Menorrhagia0GP1BB CL E G H28124440OMIM:231200BERNARD-SOULIER SYNDROME; BSS8
HP:0000132HP:0000132Menorrhagia0GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 11.24
HP:0000132HP:0000132Menorrhagia0GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent21
HP:0000132HP:0000132Menorrhagia0GP9 CL E G H28154444OMIM:231200BERNARD-SOULIER SYNDROME; BSS21
HP:0000132HP:0000132Menorrhagia0HPS4 CL E G H8978115844OMIM:614073Hermansky-Pudlak syndrome 4.123
HP:0000132HP:0000132Menorrhagia0HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5.105
HP:0000132HP:0000132Menorrhagia0ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia.69
HP:0000132HP:0000132Menorrhagia0ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional69
HP:0000132HP:0000132Menorrhagia0ITGB3 CL E G H36906156OMIM:619271BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT2480
HP:0000132HP:0000132Menorrhagia0ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional80
HP:0000132HP:0000132Menorrhagia0ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0000132HP:0000132Menorrhagia0LMAN1 CL E G H39986631ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040283 - Occasional56
HP:0000132HP:0000132Menorrhagia0MCFD2 CL E G H9041118451ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040283 - Occasional77
HP:0000132HP:0000132Menorrhagia0MCFD2 CL E G H9041118451OMIM:613625Factor V and factor VIII, combined deficiency of.77
HP:0000132HP:0000132Menorrhagia0MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.297
HP:0000132HP:0000132Menorrhagia0MYH9 CL E G H46277579ORPHA:182050MYH9-related diseaseHP:0040282 - Frequent297
HP:0000132HP:0000132Menorrhagia0NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome.127
HP:0000132HP:0000132Menorrhagia0PLAU CL E G H53289052OMIM:601709Quebec platelet disorder.50
HP:0000132HP:0000132Menorrhagia0PRKACG CL E G H55689382OMIM:616176Bleeding disorder, platelet-type, 19.2
HP:0000132HP:0000132Menorrhagia0PRLR CL E G H56189446ORPHA:397685Familial hyperprolactinemiaHP:0040283 - Occasional2
HP:0000132HP:0000132Menorrhagia0PRLR CL E G H56189446OMIM:615555HYPERPROLACTINEMIAHP:0040283 - Occasional2
HP:0000132HP:0000132Menorrhagia0SERPINE1 CL E G H50548583ORPHA:465Congenital plasminogen activator inhibitor type 1 deficiencyHP:0040282 - Frequent39
HP:0000132HP:0000132Menorrhagia0SERPINE1 CL E G H50548583OMIM:613329Plasminogen activator inhibitor-1 deficiency.39
HP:0000132HP:0000132Menorrhagia0SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type IbHP:0040283 - Occasional110
HP:0000132HP:0000132Menorrhagia0SLFN14 CL E G H34261832689OMIM:616913Bleeding disorder, platelet-type, 20.6
HP:0000132HP:0000132Menorrhagia0VWF CL E G H745012726OMIM:193400Von willebrand disease, type 1.533
HP:0000132HP:0000132Menorrhagia0VWF CL E G H745012726OMIM:613554Von willebrand disease, type 2.533
HP:0000132HP:0000132Menorrhagia0VWF CL E G H745012726OMIM:277480Von willebrand disease, type 3.533


Genes (31) :BLOC1S3 BLOC1S5 DIAPH1 F10 F11 F13A1 F13B F2 F5 F7 F8 FLI1 GP1BA GP1BB GP6 GP9 HPS4 HPS5 ITGA2B ITGB3 LMAN1 MCFD2 MYH9 NBEAL2 PLAU PRKACG PRLR SERPINE1 SLC37A4 SLFN14 VWF

Diseases (42) :OMIM:614077 OMIM:619172 OMIM:124900 ORPHA:328 OMIM:227600 ORPHA:329 ORPHA:331 ORPHA:325 OMIM:613679 ORPHA:326 OMIM:227400 ORPHA:327 OMIM:227500 ORPHA:177926 ORPHA:169802 OMIM:617443 ORPHA:274 OMIM:153670 OMIM:231200 OMIM:614201 OMIM:614073 OMIM:614074 OMIM:273800 ORPHA:849 OMIM:619271 OMIM:619267 ORPHA:35909 OMIM:613625 OMIM:155100 ORPHA:182050 OMIM:139090 OMIM:601709 OMIM:616176 ORPHA:397685 OMIM:615555 ORPHA:465 OMIM:613329 ORPHA:79259 OMIM:616913 OMIM:193400 OMIM:613554 OMIM:277480
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.